サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1423186

アレルギー免疫療法市場レポート：治療タイプ、アレルギータイプ、流通チャネル、地域別、2024年～2032年

Allergy Immunotherapies Market Report by Treatment Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy ), Allergy Type, Distribution Channel, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 141 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
アレルギー免疫療法市場レポート：治療タイプ、アレルギータイプ、流通チャネル、地域別、2024年～2032年
出版日: 2024年01月30日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アレルギー免疫療法の世界市場規模は2023年に31億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに67億米ドルに達し、2024年から2032年の間に8.7%の成長率（CAGR）を示すと予測しています。

アレルギー免疫療法は、減感作療法または低感作療法とも呼ばれ、様々な食物、薬物、ハチ毒、イネ科花粉、イエダニなどのアレルゲンに対するアレルギー反応の予防医療です。アレルゲンの量を徐々に増やすことにより、免疫系の反応を変化させる。治療を開始する前に、アレルギー専門医と患者はアレルギー症状の誘発因子を分析し、アレルゲンを確認するために皮膚検査や血液検査を行うこともあります。アレルギー免疫療法は、炎症を抑え、長期的な影響を与え、免疫寛容を高め、病気の経過を変え、患者の生活の質を改善するのに役立ちます。

近年、免疫系の働きに影響を与えるさまざまな環境要因や生活習慣が原因で、世界中でアレルギーの有病率が増加しています。アレルギー免疫療法に対する意識の高まり、所得水準の上昇、ヘルスケア支出の増加に伴い、高度で長期的な治療オプションに対する需要が増加しており、これが市場の成長を促しています。さらに、世界中の政府・非政府組織による複数の取り組みにより、臨床研究開発予算が増加していることも、市場の成長を後押ししています。さらに、最新の医薬品開発技術により、製薬企業はさまざまなアレルギーを治療するための効率的な免疫療法を開発しています。このことは、アレルギー診断分野の進歩と相まって、世界のアレルギー免疫療法市場の成長を促進しています。

本レポートで扱う主な質問

  • 2023年のアレルギー免疫療法の世界市場規模は？
  • 2024年から2032年にかけてのアレルギー免疫療法の世界市場の予想成長率は？
  • アレルギー免疫療法の世界市場を牽引する主要因は何か？
  • COVID-19がアレルギー免疫療法の世界市場に与えた影響は？
  • 治療タイプ別のアレルギー免疫療法の世界市場の内訳は？
  • アレルギータイプ別のアレルギー免疫療法の世界市場内訳は？
  • アレルギー免疫療法の世界市場における流通チャネル別の区分は？
  • アレルギー免疫療法の世界市場における主要地域は？
  • アレルギー免疫療法の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 アレルギー免疫療法の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場内訳：治療タイプ別
  • 市場内訳：アレルギータイプ別
  • 市場内訳：流通チャネル別
  • 市場内訳：地域別
  • 市場予測

第6章 市場内訳：治療タイプ別

  • 皮下免疫療法（SCIT）
    • 市場動向
    • 市場予測
  • 舌下免疫療法（SLIT）
    • 市場動向
    • 市場予測

第7章 市場内訳：アレルギータイプ別

  • アレルギー性鼻炎
    • 市場動向
    • 市場予測
  • 喘息
    • 市場動向
    • 市場予測
  • 食物アレルギー
    • 市場動向
    • 市場予測
  • 毒物アレルギー
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 欧州
    • 市場動向
    • 市場予測
  • 北米
    • 市場動向
    • 市場予測
  • アジア太平洋
    • 市場動向
    • 市場予測
  • 中東・アフリカ
    • 市場動向
    • 市場予測
  • ラテンアメリカ
    • 市場動向
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

  • 価格指標
  • 価格構造
  • マージン分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • ALK-Abello A/S
    • Allergy Therapeutics
    • Stallergenes Greer
    • HAL Allergy Holding B.V.
    • DBV Technologies
    • Merck KGaA
    • Aimmune Therapeutics
    • Circassia Pharmaceuticals
    • Anergis SA
    • Biomay AG
図表

List of Figures

  • Figure 1: Global: Allergy Immunotherapies Market: Major Drivers and Challenges
  • Figure 2: Global: Allergy Immunotherapies Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Allergy Immunotherapies Market: Breakup by Treatment Type (in %), 2023
  • Figure 4: Global: Allergy Immunotherapies Market: Breakup by Allergy Type (in %), 2023
  • Figure 5: Global: Allergy Immunotherapies Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Allergy Immunotherapies Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Allergy Immunotherapies Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Allergy Immunotherapies Industry: SWOT Analysis
  • Figure 9: Global: Allergy Immunotherapies Industry: Value Chain Analysis
  • Figure 10: Global: Allergy Immunotherapies Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Allergy Immunotherapies (Allergic Rhinitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Allergy Immunotherapies (Allergic Rhinitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Allergy Immunotherapies (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Allergy Immunotherapies (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Allergy Immunotherapies (Food Allergy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Allergy Immunotherapies (Food Allergy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Allergy Immunotherapies (Venom Allergy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Allergy Immunotherapies (Venom Allergy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Allergy Immunotherapies (Other Allergy Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Allergy Immunotherapies (Other Allergy Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Allergy Immunotherapies Market: Sales through Hospital Pharmacy (in Million US$), 2018 & 2023
  • Figure 26: Global: Allergy Immunotherapies Market Forecast: Sales through Hospital Pharmacy (in Million US$), 2024-2032
  • Figure 27: Global: Allergy Immunotherapies Market: Sales through Retail Pharmacy (in Million US$), 2018 & 2023
  • Figure 28: Global: Allergy Immunotherapies Market Forecast: Sales through Retail Pharmacy (in Million US$), 2024-2032
  • Figure 29: Global: Allergy Immunotherapies Market: Online Sales (in Million US$), 2018 & 2023
  • Figure 30: Global: Allergy Immunotherapies Market Forecast: Online Sales (in Million US$), 2024-2032
  • Figure 31: Europe: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Europe: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: North America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: North America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Asia Pacific: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Asia Pacific: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Middle East and Africa: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Middle East and Africa: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Latin America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Latin America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Allergy Immunotherapies Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Allergy Immunotherapies Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 3: Global: Allergy Immunotherapies Market Forecast: Breakup by Allergy Type (in Million US$), 2024-2032
  • Table 4: Global: Allergy Immunotherapies Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Allergy Immunotherapies Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Allergy Immunotherapies Market Structure
  • Table 7: Global: Allergy Immunotherapies Market: Key Players
目次
Product Code: SR112024A1401

Abstract

The global allergy immunotherapies market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2032, exhibiting a growth rate (CAGR) of 8.7% during 2024-2032.

Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system's response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient's life.

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global allergy immunotherapies market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on treatment type, allergy type and distribution channel.

Breakup by Treatment Type:

Subcutaneous Immunotherapy (SCIT)

Sublingual Immunotherapy (SLIT)

Breakup by Allergy Type:

Allergic Rhinitis

Asthma

Food Allergy

Venom Allergy

Others

Breakup by Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Breakup by Region:

Europe

North America

Asia Pacific

Middle East and Africa

Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Holding B.V., DBV Technologies, Merck KGaA, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG, etc.

Key Questions Answered in This Report

  • 1. What was the size of the global allergy immunotherapies market in 2023?
  • 2. What is the expected growth rate of the global allergy immunotherapies market during 2024-2032?
  • 3. What are the key factors driving the global allergy immunotherapies market?
  • 4. What has been the impact of COVID-19 on the global allergy immunotherapies market?
  • 5. What is the breakup of the global allergy immunotherapies market based on the treatment type?
  • 6. What is the breakup of the global allergy immunotherapies market based on the allergy type?
  • 7. What is the breakup of the global allergy immunotherapies market based on the distribution channel?
  • 8. What are the key regions in the global allergy immunotherapies market?
  • 9. Who are the key players/companies in the global allergy immunotherapies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Allergy Immunotherapies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Treatment Type
  • 5.5 Market Breakup by Allergy Type
  • 5.6 Market Breakup by Distribution Channel
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Treatment Type

  • 6.1 Subcutaneous Immunotherapy (SCIT)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sublingual Immunotherapy (SLIT)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Allergy Type

  • 7.1 Allergic Rhinitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Food Allergy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Venom Allergy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 Europe
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 North America
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

  • 13.1 Price Indicators
  • 13.2 Price Structure
  • 13.3 Margin Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 ALK-Abello A/S
    • 14.3.2 Allergy Therapeutics
    • 14.3.3 Stallergenes Greer
    • 14.3.4 HAL Allergy Holding B.V.
    • 14.3.5 DBV Technologies
    • 14.3.6 Merck KGaA
    • 14.3.7 Aimmune Therapeutics
    • 14.3.8 Circassia Pharmaceuticals
    • 14.3.9 Anergis SA
    • 14.3.10 Biomay AG